Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Allovir, Inc. (ALVR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/18/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "AlloVir Reports Second Quarter 2023 Financial Results"
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AlloVir Reports First Quarter 2023 Financial Results"
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 144 Form 144 - Report of proposed sale of securities:
04/20/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
03/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/31/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/21/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AlloVir Appoints Derek Adams, Ph.D., to Board of Directors"
02/09/2023 SC 13G/A FMR LLC reports a 7.6% stake in ALLOVIR INC
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AlloVir Announces Plans to Complete Enrollment in Three Phase 3 Posoleucel Studies in 2023"
11/21/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy